tetano
Editor, Senior Moderator
Sci Rep
. 2023 Aug 5;13(1):12733.
doi: 10.1038/s41598-023-39941-6. Impact of prophylactic hydroxychloroquine on ultrastructural impairment and cellular SARS-CoV-2 infection in different cells of bronchoalveolar lavage fluids of COVID-19 patients
Shikha Chaudhary[SUP] 1 [/SUP], Arti Joshi[SUP] 1 [/SUP], Kishore Sesham[SUP] 1 [/SUP], Preeti Rai[SUP] 1 [/SUP], Shailendra Kumar[SUP] 2 [/SUP], Asit Ranjan Mridha[SUP] 3 [/SUP], Upendra Baitha[SUP] 4 [/SUP], Tapas Chandra Nag[SUP] 1 [/SUP], Subhash Chandra Yadav[SUP] 5 [/SUP]
Affiliations
Many drugs were recommended as antiviral agents for infection control and effective therapy to reduce the mortality rate for COVID-19 patients. Hydroxychloroquine (HCQ), an antimalarial drug, has been controversially recommended for prophylactic use in many countries, including India, to control SARS-CoV-2 infections. We have explored the effect of prophylactic HCQ from the cells of bronchoalveolar lavage fluids from COVID-19-induced acute respiratory distress syndrome patients to determine the level of infection and ultrastructural alterations in the ciliated epithelium, type II pneumocytes, alveolar macrophages, neutrophils, and enucleated granulocytes. Ultrastructural investigation of ciliated epithelium and type II pneumocytes showed lesser infections and cellular impairment in the prophylactic HCQ[SUP]+[/SUP] group than HCQ[SUP]-[/SUP] group. However, macrophages and neutrophils displayed similar infection and ultrastructural alterations in both patient groups. The enucleated fragments of granulocytes showed phagocytosis of the matured virus in HCQ[SUP]+[/SUP] groups. The present report unveils the ultrastructural proof to complement the paradox regarding the role of prophylactic HCQ in COVID-19 patients.
. 2023 Aug 5;13(1):12733.
doi: 10.1038/s41598-023-39941-6. Impact of prophylactic hydroxychloroquine on ultrastructural impairment and cellular SARS-CoV-2 infection in different cells of bronchoalveolar lavage fluids of COVID-19 patients
Shikha Chaudhary[SUP] 1 [/SUP], Arti Joshi[SUP] 1 [/SUP], Kishore Sesham[SUP] 1 [/SUP], Preeti Rai[SUP] 1 [/SUP], Shailendra Kumar[SUP] 2 [/SUP], Asit Ranjan Mridha[SUP] 3 [/SUP], Upendra Baitha[SUP] 4 [/SUP], Tapas Chandra Nag[SUP] 1 [/SUP], Subhash Chandra Yadav[SUP] 5 [/SUP]
Affiliations
- PMID: 37543667
- PMCID: PMC10404249
- DOI: 10.1038/s41598-023-39941-6
Many drugs were recommended as antiviral agents for infection control and effective therapy to reduce the mortality rate for COVID-19 patients. Hydroxychloroquine (HCQ), an antimalarial drug, has been controversially recommended for prophylactic use in many countries, including India, to control SARS-CoV-2 infections. We have explored the effect of prophylactic HCQ from the cells of bronchoalveolar lavage fluids from COVID-19-induced acute respiratory distress syndrome patients to determine the level of infection and ultrastructural alterations in the ciliated epithelium, type II pneumocytes, alveolar macrophages, neutrophils, and enucleated granulocytes. Ultrastructural investigation of ciliated epithelium and type II pneumocytes showed lesser infections and cellular impairment in the prophylactic HCQ[SUP]+[/SUP] group than HCQ[SUP]-[/SUP] group. However, macrophages and neutrophils displayed similar infection and ultrastructural alterations in both patient groups. The enucleated fragments of granulocytes showed phagocytosis of the matured virus in HCQ[SUP]+[/SUP] groups. The present report unveils the ultrastructural proof to complement the paradox regarding the role of prophylactic HCQ in COVID-19 patients.